Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Gynesonics, Inc. · Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

137 daysmedian FDA review time
254 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K250705Sonata Transcervical Fibroid Ablation System 2.2Gynesonics, Inc.2025-04-02230
K240503Sonata Transcervical Fibroid Ablation System 2.2Gynesonics, Inc.2024-07-171470
K233848Sonata Transcervical Fibroid Ablation System 2.2 (SONATA2-22Gynesonics, Inc.2023-12-21160
K222304Sonata Transcervical Fibroid Ablation System 2.2Gynesonics, Inc.2022-11-08990
K211535Sonata Transcervical Fibroid Ablation System 2.2Gynesonics, Inc.2021-06-17300
K193516Sonata® Sonography-Guided Transcervical Fibroid Ablation SysGynesonics, Inc.2020-05-041370
K173703Sonata Sonography-Guided Transcervical Fibroid Ablation SystGynesonics, Inc.2018-08-152540
K061153GYNESONICS EC6 TRANSDUCERGynesonics, Inc.2006-10-271840

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda